VOGLIGRESS M (Metformin (500mg) + Voglibose (0.3mg))

Vogligress-M 0.3mg Tablet is classified as an anti-diabetic medication designed to manage type 2 diabetes mellitus in adults. This product is a combination of components that work synergistically to assist individuals in maintaining stable blood glucose levels. It is essential for patients to take the medication with food to enhance absorption and efficacy. Consistency is key, and patients are encouraged to take the tablet at the same time each day as prescribed by their healthcare provider. The doctor will determine the appropriate dosage based on individual blood sugar readings, which may necessitate adjustments over time to optimize treatment outcomes. It is crucial to continue using this medication even if glucose levels appear stable, as discontinuation without medical advice could lead to increased blood sugar, potentially resulting in severe complications such as renal failure, vision impairment, neuropathy, or amputation. This medication should be part of a comprehensive diabetes management plan that includes a nutritious diet, consistent physical activity, and weight management as suggested by the healthcare provider. While some patients may experience side effects such as nausea, changes in taste, reduced appetite, gas, abdominal discomfort, diarrhea, or skin rashes, these effects are often mild and temporary. Should any side effects persist or cause concern, patients should seek guidance from their doctor. It is advised against using this medication in individuals with type 1 diabetes, diabetic ketoacidosis, or serious kidney or liver impairments. Prior to starting this treatment, patients must inform their doctor of any history of heart disease. Regular monitoring of blood glucose levels as well as periodic blood tests to assess blood cell counts and liver function are important while using this medication.